Caris Life Sciences Publishes Study Validating Caris AI Insights for Temozolomide Benefit in Glioblastoma Patients

Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine ...
AlphaGalileo

Nature Reviews Drug Discovery | Target Identification and Assessment in the Era of AI

Insilico Medicine (“Insilico”, 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven biotechnology ...

Genomics Services Market Set to Reach $24.0 Billion by 2033, Growing at 11.2% CAGR

According to a new report published by Allied Market Research, the global Genomics Services Market was valued at $8.3 billion ...

Allied Market Research: Genomics Services Market Set to Reach $24.0 Billion by 2033, Growing at 11.2% CAGR

Increasing prevalence of bleeding disorders, rising number of surgical procedures, aging population, and growing focus on interoperability are the major factors which drive global market growth.WILMIN ...
Frontiers

Advancing Plant Abiotic Stress Research with Integrated Multi-Omics Technologies

Abiotic stresses such as heat, drought, salinity, and intense light significantly impact plant productivity in varying ...

Caris Life Sciences, Inc. (CAI) Coverage Begins at Neutral as Piper Cites Need for Growth Acceleration

We recently compiled a list of the Top 10 AI-Powered Biotech Stocks to Buy Right Now. Caris Life Sciences, Inc. is among the ...
TMCnet

Caris Life Sciences to Present at the BofA Securities 2026 Health Care Conference and the Goldman Sachs 47th Annual Global Healthcare Conference

Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine ...
Drug Target Review

Variant or viable target? How resolving complex genomic regions is reshaping rare disease therapeutics

Dr Aaron Wenger reveals how improvements in long-read sequencing technology is enabling the elucidation of complex disease ...

Understanding the origins of Hodgkin lymphoma cells could lead to better diagnostics

For the first time, Weill Cornell Medicine researchers have demonstrated that Hodgkin lymphoma cancer cells from patient ...
Le Lézard

Veracyte Announces New Data at AUA 2026 Highlighting the Power of the Decipher Portfolio to Advance Personalized Care in Urologic Cancers

Veracyte, Inc. , a leading cancer diagnostics company, announced today that more than 15 studies focused on the Decipher portfolio will be presented at the 2026 American Urological Association (AUA) ...
Technology Networks

How Cells With Cancer-Causing Mutations Corrupt the Local Environment

Researchers uncover how mutant lung cells reshape surrounding tissue through signaling loops with fibroblasts and immune ...
eLife

Neurotrophin-3 produced by motor neurons non-cell autonomously regulate the development of pre-motor interneurons in the developing spinal cord

This is a useful study that seeks to elucidate the molecular mechanisms underlying spinal motor circuit assembly. The authors demonstrate that loss of Onecut transcription factors in spinal motor ...